Rheumatoid arthritis patients' motivations for accepting or resisting disease-modifying antirheumatic drug treatment regimens.

about

Timing and impact of decisions to adjust disease-modifying antirheumatic drug therapy for rheumatoid arthritis patients with active disease.

P2860

Q47262286-6E81CC46-6B3F-4704-90E4-D0679D63E5A9

P2860

Rheumatoid arthritis patients' motivations for accepting or resisting disease-modifying antirheumatic drug treatment regimens.

Item

http://www.wikidata.org/entity/Q38675559

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Rheumatoid arthritis patients' ...... matic drug treatment regimens.

@en

type

Item

label

Rheumatoid arthritis patients' ...... matic drug treatment regimens.

@en

prefLabel

Rheumatoid arthritis patients' ...... matic drug treatment regimens.

@en

P1476

Rheumatoid Arthritis Patients' ...... umatic Drug Treatment Regimens

@en

P2093

Ilinca D Metes

http://www.w3.org/2001/XMLSchema#string

Judy C Chang

http://www.w3.org/2001/XMLSchema#string

Julie M Donohue

http://www.w3.org/2001/XMLSchema#string

Marc C Levesque

http://www.w3.org/2001/XMLSchema#string

Mark S Roberts

http://www.w3.org/2001/XMLSchema#string

Yomei Shaw

http://www.w3.org/2001/XMLSchema#string

P2860

Shared decision making: a model for clinical practice

A qualitative interview study: patient accounts of medication use in early rheumatoid arthritis from symptom onset to early postdiagnosis

Understanding why rheumatoid arthritis patient treatment preferences differ by race.

Shared decision-making in the medical encounter: what does it mean? (or it takes at least two to tango).

Understanding how patients (vs physicians) approach the decision to escalate treatment: a proposed conceptual model.

Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in Medicare managed care plans

Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.

The design of a low literacy decision aid about rheumatoid arthritis medications developed in three languages for use during the clinical encounter.

Patients' adherence-related beliefs about methotrexate: a qualitative study of the role of written patient information.

Prescribing practices in a US cohort of rheumatoid arthritis patients before and after publication of the American College of Rheumatology treatment recommendations.

P304

533-541

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ACR.23301

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kaleb Michaud

P577

2018-03-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28575542

http://www.w3.org/2001/XMLSchema#string

P932

5712284

http://www.w3.org/2001/XMLSchema#string

Rheumatoid arthritis patients' motivations for accepting or resisting disease-modifying antirheumatic drug treatment regimens.

about

P2860

P2860

Rheumatoid arthritis patients' motivations for accepting or resisting disease-modifying antirheumatic drug treatment regimens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932